Profiling drug candidates

for liver disease

Generating pre-clinical human data for therapeutic candidates with in-vitro liver and metabolic disease models.


Enabling cures for liver disease through highly predictive in vitro modeling

We generate high-quality, phenotypically relevant disease modeled hepatocytes that can be utilized to screen compounds.

Specialist CRO focused on delivering liver and metabolic disease models

icons_dark blue2
Highly Predictive

Opti-HEPs successfully recapitulate key aspects of disease pathophysiology across a wide-range of conditions that affect different aspects of liver function.

icons_dark blue3


DefiniGEN’s proprietary differentiation protocol permits large-scale generation of hepatocyte-like cells with field leading purity and functionality.

icons_dark blue
Optimized Bioassay Development

Optimized bioassays that can accurately evaluate compound potency, efficacy and delivery.

Scientific expertise

Advance your scientific discoveries with our tailored disease modeling products and services.